Omicron News and Research

RSS

Novel screening method detects new N501T SARS-CoV-2 variant

Researchers develop two SARS-CoV-2 Mutation Discrimination assays that have been designed to detect 501 and 484 mutations on the spike protein.

17 Mar 2022

Study finds out-of-pocket spending for health care after COVID-19 hospital stay

Millions of Americans have needed hospitalization for COVID-19 since the pandemic began, including hundreds of thousands in the recent Omicron surge.

17 Mar 2022

It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

As immunocompromised people across the country work to get Evusheld, a potentially lifesaving covid therapy, several hundred providers of the injections were removed from a federal dataset on Wednesday night, making the therapy even harder to locate.

17 Mar 2022

Omicron SARS-CoV-2 variant is more stable than its ancestral strain on smooth and porous surfaces

Researchers showed that the SARS-CoV-2 Omicron variant of concern is more stable on smooth and porous surfaces compared to its five ancestral strains.

17 Mar 2022

Study finds co-infected individuals carrying two distinct lineages of SARS-CoV-2 in Argentina

Researchers used molecular surveillance to identify cases of co-infection with SARS-CoV-2 variants of concern Delta and Omicron reported in Argentina during December 2021 and January 2022.

17 Mar 2022

MHRA authorizes new medicine for COVID-19 prevention

A new medicine, Evusheld (tixagevimab/cilgavimab), has today been authorised for COVID-19 prevention by the Medicines and Healthcare products Regulatory Agency (MHRA) after meeting the UK regulatory standards of safety, quality and effectiveness.

17 Mar 2022

Novel mathematical model could predict the evolutionary trend of SARS-CoV-2

Researchers used a novel mathematical model to simulate SARS-CoV-2 dynamics inside the host.

17 Mar 2022

Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion

Researchers constructed a novel fusion inhibitor−based recombinant protein, referred to as 5−Helix, to block SARS-CoV-2 spike-mediated cell-cell fusion.

17 Mar 2022

The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

Researchers compared the efficacy of booster doses of heterologous intramuscular and aerosolized adenovirus-vectored vaccine, a recombinant protein-based ZF2001 vaccine, and homologous CoronaVac vaccines.

17 Mar 2022

The safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in adults previously vaccinated with BBIBP-CorV

Researchers assessed the safety profile and immunogenicity of a heterologous NVSI-06-08 boost against SARS-CoV-2 variants in individuals doubly vaccinated with the inactivated vaccine BBIBP-CorV.

17 Mar 2022

Frail and older males more vulnerable to COVID-19 than females

Researchers evaluated the association of biological sex, frailty, and age with the vaccine-elicited immunity against SARS-CoV-2.

17 Mar 2022

Vaccine effectiveness against COVID-19 severity in the elderly

Researchers assessed vaccine effectiveness against SARS-CoV-2 infection in elderly patients before and after the spread of the SARS-CoV-2 Omicron variant of concern.

17 Mar 2022

Evidence of lower COVID-19 severity in SARS-CoV-2 Omicron infection compared to Delta infection

Researchers compared COVID-19 severity among hospitalized patients infected with the SARS-CoV-2 Delta and Omicron variants in Norway.

17 Mar 2022

The effects of anti-SARS-CoV-2 monoclonal antibodies on pregnant and postpartum women

Researchers examine the safety and efficacy of mAbs in pregnant and postpartum women with COVID-19.

16 Mar 2022

Wastewater monitoring reveals emergence and spread of SARS-CoV-2 Omicron in Alberta

Researchers utilize variant-specific RT-qPCR assays to monitor wastewater to monitor the prevalence of the Omicron and Delta variants.

16 Mar 2022

Tracking the mutating coronavirus variants

Viruses continuously and naturally evolve. To track coronavirus variants, we need to think like Darwin.

16 Mar 2022

Young adults protected by booster COVID-19 vaccine during Omicron dominant period

Researchers estimate the impact of COVID-19 booster doses on infection in a vaccinated population of young adults during Omicron-dominant period.

16 Mar 2022

Maternal and neonatal outcomes during UK's SARS-CoV-2 Omicron wave

Researchers describe the characteristics of pregnant women hospitalized due to COVID-19.

15 Mar 2022

Anti-spike IgG dynamics after 2nd BNT162b2 COVID-19 vaccine dose in Japanese health care workers

Researchers investigate the dynamics of anti-spike IgG levels against the SARS-CoV-2 spike protein in Japanese healthcare workers.

15 Mar 2022

Croup: A previously unrecognized complication of COVID-19 in young children

The omicron surge has led to a previously unrecognized complication of COVID-19 in young children: croup. In the first peer-reviewed report to date, physicians at Boston Children's Hospital describe 75 children who came to the hospital's emergency department (ED) with croup and COVID-19 from March 1, 2020 through January 15, 2022.

15 Mar 2022

Omicron News and Research

Novel screening method detects new N501T SARS-CoV-2 variant

Study finds out-of-pocket spending for health care after COVID-19 hospital stay

It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

Omicron SARS-CoV-2 variant is more stable than its ancestral strain on smooth and porous surfaces

Study finds co-infected individuals carrying two distinct lineages of SARS-CoV-2 in Argentina

MHRA authorizes new medicine for COVID-19 prevention

Novel mathematical model could predict the evolutionary trend of SARS-CoV-2

Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion

The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

The safety and immunogenicity of NVSI-06-08 as a heterologous booster dose in adults previously vaccinated with BBIBP-CorV

Frail and older males more vulnerable to COVID-19 than females

Vaccine effectiveness against COVID-19 severity in the elderly

Evidence of lower COVID-19 severity in SARS-CoV-2 Omicron infection compared to Delta infection

The effects of anti-SARS-CoV-2 monoclonal antibodies on pregnant and postpartum women

Wastewater monitoring reveals emergence and spread of SARS-CoV-2 Omicron in Alberta

Tracking the mutating coronavirus variants

Young adults protected by booster COVID-19 vaccine during Omicron dominant period

Maternal and neonatal outcomes during UK's SARS-CoV-2 Omicron wave

Anti-spike IgG dynamics after 2nd BNT162b2 COVID-19 vaccine dose in Japanese health care workers

Croup: A previously unrecognized complication of COVID-19 in young children

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News